Autonomous Medical Devices Incorporated
AMDI is a California-based company dedicated to developing and manufacturing point-of-care diagnostic devices using innovative technology, microfluidics, protein engineering, and cloud connectivity. Their mission is to create patient-centric, cloud-connected diagnostics that provide actionable information within minutes, with products manufactured in an ISO:13485 certified facility in Santa Ana, CA.
Industries
Nr. of Employees
medium (51-250)
Autonomous Medical Devices Incorporated
Patents
Chelator-coated field effect transistor and devices and methods using same
US-12111313-B2
View DetailsApparatus for automatic sampling of biological species employing disk microfluidics system
US-12023674-B2
View DetailsDetection of cardiac troponin or biological markers via shear horizontal surface acoustic wave biosensor using a wet-dry bioanalytical technique
US-11567068-B2
View DetailsApparatus for automatic sampling of biological species employing an amplification with a magnetic nanoparticle and propulsion method
US-11358140-B2
View DetailsApparatus and method for overcoming minimal mass sensitivity limitations in a shear horizontal surface acoustic wave biosensor
US-11293919-B2
View DetailsApparatus for automatic sampling of biological species employing disk microfluidics system
US-11224874-B2
View Details
Chelator-coated field effect transistor and devices and methods using same
US-12111313-B2
View DetailsApparatus for automatic sampling of biological species employing disk microfluidics system
US-12023674-B2
View DetailsDetection of cardiac troponin or biological markers via shear horizontal surface acoustic wave biosensor using a wet-dry bioanalytical technique
US-11567068-B2
View DetailsApparatus for automatic sampling of biological species employing an amplification with a magnetic nanoparticle and propulsion method
US-11358140-B2
View DetailsApparatus and method for overcoming minimal mass sensitivity limitations in a shear horizontal surface acoustic wave biosensor
US-11293919-B2
View DetailsApparatus for automatic sampling of biological species employing disk microfluidics system
US-11224874-B2
View DetailsProducts
Ultrafast RT‑PCR point‑of‑care system (intended for CLIA‑waived use)
A compact molecular diagnostic system designed to deliver RT‑PCR results at the time of care in under 10 minutes for multiple respiratory targets; described as intended for CLIA‑waived environments and planned for regulatory submission.
Rapid sample preparation system using hyperbaric heating (RUO)
A research‑use‑only sample‑preparation platform that uses hyperbaric heating to lyse samples and release nucleic acids in under two minutes, intended to remove the need for conventional extraction kits and accelerate molecular workflows.
Quantitative neutralizing antibody IgG assay (RUO)
A research‑use‑only immunochemistry assay for quantifying neutralizing antibody activity and IgG levels; reported to correlate strongly with live‑virus neutralization assays across clinical samples and to provide faster, lower‑cost results compared with live‑virus methods.
Ultrafast RT‑PCR point‑of‑care system (intended for CLIA‑waived use)
A compact molecular diagnostic system designed to deliver RT‑PCR results at the time of care in under 10 minutes for multiple respiratory targets; described as intended for CLIA‑waived environments and planned for regulatory submission.
Rapid sample preparation system using hyperbaric heating (RUO)
A research‑use‑only sample‑preparation platform that uses hyperbaric heating to lyse samples and release nucleic acids in under two minutes, intended to remove the need for conventional extraction kits and accelerate molecular workflows.
Quantitative neutralizing antibody IgG assay (RUO)
A research‑use‑only immunochemistry assay for quantifying neutralizing antibody activity and IgG levels; reported to correlate strongly with live‑virus neutralization assays across clinical samples and to provide faster, lower‑cost results compared with live‑virus methods.
Services
Opportunities for external collaboration leveraging in‑house expertise in protein engineering, microfluidics, sample prep, assay development, and manufacturing.
Provision of clinical quick reference guides and instrument documentation to support clinical implementation and user training.
Execution and management of federally funded development projects to advance diagnostic systems (example: NIH RADx awards).
Opportunities for external collaboration leveraging in‑house expertise in protein engineering, microfluidics, sample prep, assay development, and manufacturing.
Provision of clinical quick reference guides and instrument documentation to support clinical implementation and user training.
Execution and management of federally funded development projects to advance diagnostic systems (example: NIH RADx awards).
Expertise Areas
- Point‑of‑care molecular diagnostics
- Multiplex assay development
- Rapid sample preparation technologies
- Clinical study design and multicenter evaluation
Key Technologies
- Ultrafast thermal cycling PCR
- Multiplex RT‑PCR
- Hyperbaric heating sample lysis
- Microfluidics
News & Updates
AMDI announced the certification of its Quality Management System to ISO 13485:2016 by Intertek, marking a milestone as it prepares for commercialization of its rapid diagnostics platform.
AMDI announced the successful completion of its multicenter clinical study supporting FDA submission of its Mini Respiratory Panel and obtained MDSAP certification, enabling global market access.
AMDI received NIH funding to develop a rapid RT-PCR system capable of detecting multiple targets in less than 10 minutes, supporting public health responses.
AMDI announced the launch of its Autolab™ HBH system, a rapid sample prep technology that simplifies and accelerates molecular workflows.
AMDI announced the certification of its Quality Management System to ISO 13485:2016 by Intertek, marking a milestone as it prepares for commercialization of its rapid diagnostics platform.
AMDI announced the successful completion of its multicenter clinical study supporting FDA submission of its Mini Respiratory Panel and obtained MDSAP certification, enabling global market access.
AMDI received NIH funding to develop a rapid RT-PCR system capable of detecting multiple targets in less than 10 minutes, supporting public health responses.
AMDI announced the launch of its Autolab™ HBH system, a rapid sample prep technology that simplifies and accelerates molecular workflows.